The case against the pharmacy chain
CVS Pharmacy and several subsidiaries agreed to pay $315 million to resolve a Justice Department lawsuit accusing them of unlawfully dispensing medically unnecessary prescriptions for highly addictive opioids. Officials announced the settlement on Tuesday.
The suit, filed in 2024, alleged that the company supplied large volumes of opioids and other controlled substances to fuel its own profits at the expense of public health and safety. It claimed that poor staffing, performance metrics and incentive compensation pushed pharmacists to fill prescriptions quickly without confirming they were legitimate.
Federal programmes paid the bills
Many of the prescriptions at issue were billed to and reimbursed by Medicaid and other federal healthcare programmes. Associate Attorney General Stanley Woodward called the settlement a milestone in the department's effort to hold pharmacies accountable for filling prescriptions for controlled substances unlawfully.
Under the agreement, CVS must also add safeguards to ensure opioids and other controlled substances are dispensed only when medically appropriate, according to Brett Shumate, who leads the Justice Department's civil division.
CVS denies wrongdoing
CVS said its pharmacists are trained in the safe and appropriate use of all medications and that it has built programmes to help them make the best decisions for patients. The company said it strongly disagrees with the claims and that the settlement admits no wrongdoing.
Two years ago the company argued that pharmacists were being held to vague, undefined and frequently changing standards when deciding whether to fill opioid prescriptions.
A decade of settlements
Over the past ten years, drugmakers, wholesalers, pharmacies and other companies have agreed to settlements with US governments totalling more than $50 billion. Most of the money is meant to address an addiction crisis linked to more than 100,000 deaths in some years, though fatal overdoses have fallen sharply more recently.
Most of those dollars have come from state and local governments. Federal deals in the past two years included agreements with Walgreens and Walmart. For CVS, the settlement closes one case while leaving the wider question of how pharmacies should police prescribing decisions unresolved.